传递希望遏制结核 青海耐多药结核病控制项目启动


传递希望遏制结核 青海耐多药结核病控制项目启动

 
 
 
 
 
传递希望遏制结核 青海耐多药结核病控制项目启动
 

  新华网青海频道西宁09月15日电    9月14日,由省卫生厅、美国礼来公司、全球企业抗艾滋病结核病和疟疾联合会联合主办的“传递希望,遏制结核”为主题的援助中国西部青海省耐多药结核病控制公益项目正式在西宁市启动。

    据悉,此项目从本月全面启动实施,项目设计执行周期为两年,项目计划投资112万元人民币,将在全省20个重点县开展耐多药结核病防治工作。项目通过形式多样的健康教育活动,提高公众结核病防治知识知晓率,预防和降低结核病及耐多药结核病的发生;通过培训各级结核病专业技术人员和综合医疗机构医生及个体医生,建立不同模式耐多药结核病防治试点,获得经验,以此推动全省实施耐多药结核病防治工作进展。本项目将培训结核病专业和医务人员共520名,社区或群众间接受益人群预计在200万至350万之间。此项目还将充分与我省结核病防治规划及其他项目整合,填补其他项目和地方支持资金和活动的空白和不足。

    结核病是经呼吸道传播的慢性传染病,已经成为重大的公共卫生问题和社会问题。近年来,我省全面落实“重点疾病重点防治、重点地区重点预防、重点人群重点干预”的专病专防策略和现代结核病控制策略,结核病防控工作取得了明显的成效。政府领导、多部门协作、全社会参与的防治格局初步形成;如期实现了国家结核病防治规划阶段目标;结核病防治能力不断加强,防治工作质量稳步提高。(来源:青海日报 作者:李欣)

Message of hope to contain MDR-TB Qinghai TB control project started
 


Xinhua Xining, Qinghai Channel September 15 Xinhua September 14, the provincial health department, the U.S. Eli Lilly and Company, Global Business Association to Fight AIDS Tuberculosis and Malaria, co-sponsored the "message of hope, Stop TB" as the theme for assistance in western China MDR-TB control Qinghai public projects have been formally launched in Xining City.
     It is reported that this project this month to start full implementation, project design, implementation cycle of two years, the project plans to invest 1.12 million yuan, will focus on 20 counties in the province of MDR-TB prevention and control work. Project through various forms of health education activities to raise public knowledge of TB prevention and control Awareness, Prevention and Reduction of TB and MDR-TB occurring; through the training of professional and technical personnel at all levels of TB and comprehensive individual medical doctors and medical institutions to establish different modes of resistance to of multi-drug TB control pilot projects, to gain experience, thereby contributing to the province's implementation of the multi-drug resistant tuberculosis control work progress. The project will train professionals and TB, a total of 520 medical personnel, community or the people benefit indirectly from the crowd is expected between 2000000-3500000. This project will also be full and our province TB integration planning and other projects to fill the other projects and local support funds and activities of the gaps and shortcomings.

     TB is spread through the respiratory tract of chronic diseases, has become a major public health problems and social problems. In recent years, the full implementation of our province, "focus on key disease prevention and control, focusing on key areas of prevention, focusing on populations of priority interventions," the special disease prevention strategies and expertise in modern tuberculosis control strategy, TB prevention and control has achieved remarkable results. Government leadership, multi-sectoral collaboration, the whole society to participate in prevention and treatment begun to take shape; schedule to achieve the national goal of tuberculosis control at the planning stage; ability to continuously strengthen TB prevention and control quality of work improved steadily. (Source: Qinghai Daily Author: Li Xin)
 
 
 
 
 
 

[ 作者:佚名    转贴自:本站原创    点击数:196    更新时间:2009-9-15    文章录入:nnb ]

 

艾滋病或不再是绝症

价值中国网网友关注“发明艾滋病新药免费救治征集媒体见证人”

艾滋病早期治疗是康复与延长30~60年生命的保障

鸡尾酒疗法并非万能,抗药性与毒副作用导致联合疗法与中药疗法应用的迫切性

呼吁救治艾滋,关注化学新药

康生丹配合西药治疗AIDS总结

艾滋病“感染”、“免疫”与“营养”三关各期施治研究

康生丹四代新药,化学名—三合皂甙分类引述
 

艾滋病免疫重建的重要意义是挽救生命的根本 

从食品植物研究开发的治疗艾滋病新药三合皂甙〔康生丹四代〕介绍  

从食品植物研究开发的治疗艾滋病新药三合皂甙  

从食品植物研究开发的治疗艾滋病新药介绍  

艾滋病的中药  

论HIV不是AIDS的病因机制 

康生丹颗粒简介 

美国营养学家推崇“抗炎饮食”同于中医之食疗 

康生丹颗粒基础研究 

艾滋病预防及国外食疗研究 

艾滋病感染者能活多久 

专家:艾滋病早治疗能多活30年以上“隐形”感染者进入晚期才被确诊 

T细胞、T细胞亚群、 调节性(或抑制性)T细胞在艾滋病康复中的研究 

你知道为什么害怕“艾滋病”这三个字么?艾滋病不同感染期症状 

康生丹颗粒〈ksd〉对免疫抑制模型小鼠免疫功能影响实验研究-公布 

食疗与艾滋病研究-康生丹颗粒〈一〉 

艾滋病未来康复的动向分析 

艾滋病人的药膳 

首次公布康生丹提高艾滋病患者CD4的图片